Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

11.11
Delayed Data
As of Aug 18
 -0.31 / -2.71%
Today’s Change
7.85
Today|||52-Week Range
45.20
-26.38%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close11.42
Today’s open11.28
Day’s range10.99 - 11.47
Volume259,170
Average volume (3 months)638,227
Market cap$482.4M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+7.56%
Earnings growth (this year)+9.72%
Earnings growth (next 5 years)--
Revenue growth (last year)+261.96%
P/E ratioNM
Price/Sales1,973.06
Price/Book1.28

Competitors

 Today’s
change
Today’s
% change
PETQPetIQ Inc+1.56+7.41%
SCMPSucampo Pharmaceutic...+0.20+1.99%
INOInovio Pharmaceutica...+0.09+1.68%
KALAKala Pharmaceuticals...-0.36-1.66%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$330.7K
Annual profit (last year)-$116.4M
Net profit margin-35,205.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts